Updated: Apr 3, 2019
With online and presentation branding assets in place Neurana strategic communications have begun. Their new presence coincides with the start of their phase 2 clinical trial studying the efficacy and safety of Tolperisone, their lead drug candidate in treating indications around muscle spasm.
The Human Elements Design team worked with Neurana marketing to create a visual/verbal experience setting a confident tone ahead of conversations they will have with patients and investors as they continue to explore the value of their new product.
Stay tuned; more branding related experiences are yet to come!